These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 6224605
1. Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl)-retinamide. Welsch CW, DeHoog JV, Moon RC. Carcinogenesis; 1983 Sep; 4(9):1185-7. PubMed ID: 6224605 [Abstract] [Full Text] [Related]
2. Lack of an effect of dietary retinoids in chemical carcinogenesis of the mouse mammary gland: inverse relationship between mammary tumor cell anaplasia and retinoid efficacy. Welsch CW, DeHoog JV, Moon RC. Carcinogenesis; 1984 Oct; 5(10):1301-4. PubMed ID: 6237806 [Abstract] [Full Text] [Related]
3. Influence of chemopreventive agents on estradiol metabolism and mammary preneoplasia in the C3H mouse. Osborne MP, Telang NT, Kaur S, Bradlow HL. Steroids; 1990 Mar; 55(3):114-9. PubMed ID: 2139751 [Abstract] [Full Text] [Related]
4. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy. McCormick DL, Mehta RG, Thompson CA, Dinger N, Caldwell JA, Moon RC. Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843 [Abstract] [Full Text] [Related]
5. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor. Moon RC, Pritchard JF, Mehta RG, Nomides CT, Thomas CF, Dinger NM. Carcinogenesis; 1989 Sep; 10(9):1645-9. PubMed ID: 2527636 [Abstract] [Full Text] [Related]
6. Effect of N-(4-hydroxyphenyl) retinamide on food intake, growth, and mammary gland development in rats. Radcliffe JD, Moon RC. Proc Soc Exp Biol Med; 1983 Nov; 174(2):270-5. PubMed ID: 6227008 [Abstract] [Full Text] [Related]
7. Putative metabolites derived from dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz[a]anthracene. Abou-Issa HM, Duruibe VA, Minton JP, Larroya S, Dwivedi C, Webb TE. Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4181-4. PubMed ID: 2967969 [Abstract] [Full Text] [Related]
9. Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2). McCormick DL, Becci PJ, Moon RC. Carcinogenesis; 1982 Feb; 3(12):1473-6. PubMed ID: 6217919 [Abstract] [Full Text] [Related]
10. Metabolism of the chemopreventive retinoid N-(4-hydroxyphenyl)retinamide by mammary gland in organ culture. Mehta RG, Hultin TA, Moon RC. Biochem J; 1988 Dec 01; 256(2):579-84. PubMed ID: 2851995 [Abstract] [Full Text] [Related]
11. Effect of N-(4-hydroxyphenyl)retinamide on murine mammary tumor cells in culture. Bunk MJ, Telang NT, Higgins PJ, Traganos F, Sarkar NH. Nutr Cancer; 1985 Dec 01; 7(1-2):105-15. PubMed ID: 2999720 [Abstract] [Full Text] [Related]
12. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1. Poliakov E, Samuel W, Duncan T, Gutierrez DB, Mata NL, Redmond TM. PLoS One; 2017 Dec 01; 12(4):e0176487. PubMed ID: 28448568 [Abstract] [Full Text] [Related]
13. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors. Silverman J, Katayama S, Radok P, Levenstein MJ, Weisburger JH. Nutr Cancer; 1983 Dec 01; 4(3):186-91. PubMed ID: 6221232 [Abstract] [Full Text] [Related]
14. Distribution and metabolism of the retinoid, N-(4-methoxyphenyl)-all-trans-retinamide, the major metabolite of N-(4-hydroxyphenyl)-all-trans-retinamide, in female mice. Hultin TA, Filla MS, McCormick DL. Drug Metab Dispos; 1990 Dec 01; 18(2):175-9. PubMed ID: 1971569 [Abstract] [Full Text] [Related]
15. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone. Ratko TA, Detrisac CJ, Mehta RG, Kelloff GJ, Moon RC. Cancer Res; 1991 Jan 15; 51(2):481-6. PubMed ID: 1824682 [Abstract] [Full Text] [Related]
16. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen. Moon RC, Kelloff GJ, Detrisac CJ, Steele VE, Thomas CF, Sigman CC. Anticancer Res; 1992 Jan 15; 12(4):1147-53. PubMed ID: 1386970 [Abstract] [Full Text] [Related]
17. Effects of pretreatment with the retinoid N-(4-hydroxyphenyl)-all-trans-retinamide and phenobarbital on the disposition and metabolism of N-(4-hydroxyphenyl)-all-trans-retinamide in mice. Hultin TA, McCormick DL, May CM, Moon RC. Drug Metab Dispos; 1988 Jan 15; 16(6):783-8. PubMed ID: 2907453 [Abstract] [Full Text] [Related]
18. Inhibition of rat mammary carcinogenesis by an arotinoid without a polar end group (Ro 15-0778). Bollag W, Hartmann HR. Eur J Cancer Clin Oncol; 1987 Feb 15; 23(2):131-5. PubMed ID: 2965015 [Abstract] [Full Text] [Related]
19. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression. Xu H, Cheepala S, McCauley E, Coombes K, Xiao L, Fischer SM, Clifford JL. Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):969-79. PubMed ID: 16467112 [Abstract] [Full Text] [Related]
20. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Ratko TA, Detrisac CJ, Dinger NM, Thomas CF, Kelloff GJ, Moon RC. Cancer Res; 1989 Aug 15; 49(16):4472-6. PubMed ID: 2525951 [Abstract] [Full Text] [Related] Page: [Next] [New Search]